Literature DB >> 18765545

Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome.

Eri Arai1, Saori Ushijima, Hitoshi Tsuda, Hiroyuki Fujimoto, Fumie Hosoda, Tatsuhiro Shibata, Tadashi Kondo, Issei Imoto, Johji Inazawa, Setsuo Hirohashi, Yae Kanai.   

Abstract

PURPOSE: The aim of this study was to clarify genetic and epigenetic alterations occurring during renal carcinogenesis. EXPERIMENTAL
DESIGN: Copy number alterations were examined by array-based comparative genomic hybridization analysis using an array harboring 4,361 bacterial artificial chromosome clones, and DNA methylation alterations on CpG islands of the p16, human MutL homologue 1, von Hippel-Lindau, and thrombospondin 1 genes and the methylated in tumor (MINT-1, MINT-2, MINT-12, MINT-25, and MINT-31) clones were examined in 51 clear cell renal cell carcinomas (RCC).
RESULTS: By unsupervised hierarchical clustering analysis based on copy number alterations, clear cell RCCs were clustered into the two subclasses, clusters A (n=34) and B (n=17). Copy number alterations were accumulated in cluster B. Loss of chromosome 3p and gain of 5q and 7 were frequent in both clusters A and B, whereas loss of 1p, 4, 9, 13q, and 14q was frequent only in cluster B. The average number of methylated CpG islands in cluster B was significantly higher than those in cluster A. Clear cell RCCs showing higher histologic grades, vascular involvement, renal vein tumor thrombi, and higher pathologic stages were accumulated in cluster B. The recurrence-free and overall survival rates of patients in cluster B were significantly lower than those of patients in cluster A. Multivariate analysis revealed that genetic clustering was a predictor of recurrence-free survival and was independent of histologic grade and pathologic stage.
CONCLUSIONS: This genetic clustering of clear cell RCC is significantly associated with regional DNA hypermethylation and may become a prognostic indicator for patients with RCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765545     DOI: 10.1158/1078-0432.CCR-08-0443

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  21 in total

1.  Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.

Authors:  Nicole M White-Al Habeeb; Ashley Di Meo; Andreas Scorilas; Fabio Rotondo; Olena Masui; Annetta Seivwright; Manal Gabril; Andrew H A Girgis; Michael A Jewett; George M Yousef
Journal:  Clin Exp Metastasis       Date:  2015-06-03       Impact factor: 5.150

2.  Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis.

Authors:  Federico A Monzon; Karla Alvarez; Lief Peterson; Luan Truong; Robert J Amato; Joan Hernandez-McClain; Nizar Tannir; Anil V Parwani; Eric Jonasch
Journal:  Mod Pathol       Date:  2011-07-01       Impact factor: 7.842

Review 3.  Genetic and epigenetic alterations during renal carcinogenesis.

Authors:  Eri Arai; Yae Kanai
Journal:  Int J Clin Exp Pathol       Date:  2010-12-13

4.  Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.

Authors:  A Ari Hakimi; Roy Mano; Giovanni Ciriello; Mithat Gonen; Nina Mikkilineni; John P Sfakianos; Philip H Kim; Robert J Motzer; Paul Russo; Victor E Reuter; James J Hsieh; Irina Ostrovnaya
Journal:  J Urol       Date:  2014-02-08       Impact factor: 7.450

Review 5.  The Role of DNA Methylation in Renal Cell Carcinoma.

Authors:  Brittany N Lasseigne; James D Brooks
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

6.  Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.

Authors:  Timothy Ito; Jianming Pei; Essel Dulaimi; Craig Menges; Philip H Abbosh; Marc C Smaldone; David Y T Chen; Richard E Greenberg; Alexander Kutikov; Rosalia Viterbo; Robert G Uzzo; Joseph R Testa
Journal:  J Urol       Date:  2015-11-18       Impact factor: 7.450

7.  Alterations of the WNT7A gene in clear cell renal cell carcinomas.

Authors:  Aleksandr G Kondratov; Sergiy M Kvasha; Liubov A Stoliar; Alina M Romanenko; Yury M Zgonnyk; Vasily V Gordiyuk; Elena V Kashuba; Alla V Rynditch; Eugene R Zabarovsky; Vladimir I Kashuba
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

8.  Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.

Authors:  Eri Arai; Suenori Chiku; Taisuke Mori; Masahiro Gotoh; Tohru Nakagawa; Hiroyuki Fujimoto; Yae Kanai
Journal:  Carcinogenesis       Date:  2012-05-18       Impact factor: 4.944

9.  Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer.

Authors:  Shinya Akatsuka; Yoriko Yamashita; Hiroki Ohara; Yu-Ting Liu; Masashi Izumiya; Koichiro Abe; Masako Ochiai; Li Jiang; Hirotaka Nagai; Yasumasa Okazaki; Hideki Murakami; Yoshitaka Sekido; Eri Arai; Yae Kanai; Okio Hino; Takashi Takahashi; Hitoshi Nakagama; Shinya Toyokuni
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

10.  Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.

Authors:  L E Moore; E Jaeger; M L Nickerson; P Brennan; S De Vries; R Roy; J Toro; H Li; S Karami; P Lenz; D Zaridze; V Janout; V Bencko; M Navratilova; N Szeszenia-Dabrowska; D Mates; W M Linehan; M Merino; J Simko; R Pfeiffer; P Boffetta; S Hewitt; N Rothman; W-H Chow; F M Waldman
Journal:  Oncogenesis       Date:  2012-06-25       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.